BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7534146)

  • 1. Vascular toxicity associated with chemotherapy for testicular cancer.
    Gerl A
    Anticancer Drugs; 1994 Dec; 5(6):607-14. PubMed ID: 7534146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer.
    Berger CC; Bokemeyer C; Schneider M; Kuczyk MA; Schmoll HJ
    Eur J Cancer; 1995 Dec; 31A(13-14):2229-38. PubMed ID: 8652248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term complications of chemotherapy for germ cell tumours.
    Chaudhary UB; Haldas JR
    Drugs; 2003; 63(15):1565-77. PubMed ID: 12887263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erectile dysfunction with chemotherapy.
    van Basten JP; van Driel MF; Hoekstra HJ; Sleijfer DT
    Lancet; 2000 Jul; 356(9224):169. PubMed ID: 10963279
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis.
    Doll DC; List AF; Greco FA; Hainsworth JD; Hande KR; Johnson DH
    Ann Intern Med; 1986 Jul; 105(1):48-51. PubMed ID: 2424354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe vascular toxicity associated with vinblastine, bleomycin, and cisplatin chemotherapy.
    Samuels BL; Vogelzang NJ; Kennedy BJ
    Cancer Chemother Pharmacol; 1987; 19(3):253-6. PubMed ID: 2438065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute vascular toxicity after combination chemotherapy with cisplatin, vinblastine, and bleomycin for testicular cancer.
    Stefenelli T; Kuzmits R; Ulrich W; Glogar D
    Eur Heart J; 1988 May; 9(5):552-6. PubMed ID: 2456930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group.
    de Wit R; Stoter G; Kaye SB; Sleijfer DT; Jones WG; ten Bokkel Huinink WW; Rea LA; Collette L; Sylvester R
    J Clin Oncol; 1997 May; 15(5):1837-43. PubMed ID: 9164193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular toxicity associated with antineoplastic agents.
    Doll DC; Ringenberg QS; Yarbro JW
    J Clin Oncol; 1986 Sep; 4(9):1405-17. PubMed ID: 3528405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin.
    Vogelzang NJ; Torkelson JL; Kennedy BJ
    Cancer; 1985 Dec; 56(12):2765-70. PubMed ID: 2413982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer.
    Vogelzang NJ; Bosl GJ; Johnson K; Kennedy BJ
    Ann Intern Med; 1981 Sep; 95(3):288-92. PubMed ID: 6168223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual dysfunction in nonseminoma testicular cancer patients is related to chemotherapy-induced angiopathy.
    van Basten JP; Hoekstra HJ; van Driel MF; Koops HS; Droste JH; Jonker-Pool G; van de Wiel HB; Sleijfer DT
    J Clin Oncol; 1997 Jun; 15(6):2442-8. PubMed ID: 9196160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. History of testicular cancer chemotherapy: maximizing efficacy, minimizing toxicity.
    Sweeney C
    Semin Urol Oncol; 2001 Aug; 19(3):170-9. PubMed ID: 11561984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early myocardial infarction associated with chemotherapy for testicular cancer].
    Bernard P; Cellarier G; Crémades S; Gisserot O; De Jauréguiberry JP
    Rev Med Interne; 2006 Jun; 27(6):497-8. PubMed ID: 16546304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current trends in chemotherapy for metastatic nonseminomatous testicular germ cell tumors.
    Bokemeyer C
    Oncology; 1998; 55(3):177-88. PubMed ID: 9560052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Raynaud's disease after treatment with bleomycin and vinblastine].
    Dzieza-Lalowicz I; Mykała-Cieśla J
    Pol Tyg Lek; 1986 Feb; 41(7):218-9. PubMed ID: 2423995
    [No Abstract]   [Full Text] [Related]  

  • 17. Raynaud's phenomenon and cryoglobulinemia during chemotherapy for testicular carcinoma.
    Dunlop PR; Hendy-Ibbs PM
    Cancer Treat Rep; 1983 Mar; 67(3):317-8. PubMed ID: 6187453
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ischemic stroke after chemotherapy with cisplatin, etoposide and bleomycin: case report].
    Santos AJ; Malheiros SM; Borges LR; Dzik C; Nalli DG; Gabbai AA
    Arq Neuropsiquiatr; 2003 Mar; 61(1):129-33. PubMed ID: 12715037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin.
    Stoter G; Koopman A; Vendrik CP; Struyvenberg A; Sleyfer DT; Willemse PH; Schraffordt Koops H; van Oosterom AT; ten Bokkel Huinink WW; Pinedo HM
    J Clin Oncol; 1989 Aug; 7(8):1099-104. PubMed ID: 2474060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular toxicity associated with antineoplastic agents.
    Doll DC; Yarbro JW
    Semin Oncol; 1992 Oct; 19(5):580-96. PubMed ID: 1411655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.